F. Bursi, S. A. Weston, and M. M. Redfield, Systolic and diastolic heart failure in the community, JAMA, vol.296, pp.2209-2216, 2006.

, The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial, Lancet, vol.353, pp.9-13, 1999.

K. Swedberg, M. Komajda, and M. Bohm, Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study, Lancet, 2010.

, Effect of metoprolol CR/XL in chronic heart failure: metoprolol CR/XL randomised intervention trial in congestive heart failure (MERIT-HF), Lancet, vol.353, pp.2001-2007, 1999.

R. Jurkevicius, G. Sakalyte, and A. Kavoliuniene, Effects of beta blockers on left ventricular diastolic function: the importance of optimal heart rate reduction, Acta Cardiol, vol.62, pp.269-274, 2007.

A. Bergstrom, B. Andersson, and M. Edner, Effect of carvedilol on diastolic function in patients with diastolic heart failure and preserved systolic function, Results of the Swedish Doppler-echocardiographic study (SWEDIC)

, Eur J Heart Fail, vol.6, pp.453-461, 2004.

A. Cargnoni, C. Ceconi, and P. Bernocchi, Reduction of oxidative stress by carvedilol: role in maintenance of ischaemic myocardium viability, Cardiovasc Res, vol.47, pp.556-566, 2000.

G. Z. Feuerstein, T. L. Yue, and H. Y. Cheng, Myocardial protection by the novel vasodilating beta-blocker, carvedilol: potential relevance of antioxidant activity, J Hypertens Suppl, vol.11, pp.41-48, 1993.

L. A. Altwegg, L. V. Uscio, and C. Barandier, Nebivolol induces NOmediated relaxations of rat small mesenteric but not of large elastic arteries, J Cardiovasc Pharmacol, vol.36, pp.316-320, 2000.

T. Quang, T. Rozec, B. Audigane, and L. , Investigation of the different adrenoceptor targets of nebivolol enantiomers in rat thoracic aorta, Br J Pharmacol, vol.156, pp.601-608, 2009.

L. Van-heerebeek, N. Hamdani, and M. L. Handoko, Diastolic stiffness of the failing diabetic heart: importance of fibrosis, advanced glycation end products, and myocyte resting tension, Circulation, vol.117, pp.43-51, 2008.

L. Van-heerebeek, A. Somsen, and W. J. Paulus, The failing diabetic heart: focus on diastolic left ventricular dysfunction, Curr Diab Rep, vol.9, pp.79-86, 2009.

J. M. Pfeffer, M. A. Pfeffer, and E. Braunwald, Influence of chronic captopril therapy on the infarcted left ventricle of the rat, Circ Res, vol.57, pp.84-95, 1985.

P. Mulder, V. Richard, and G. Derumeaux, Role of endogenous endothelin in chronic heart failure: effect of long-term treatment with an endothelin antagonist on survival, hemodynamics, and cardiac remodeling, Circulation, vol.96, pp.1976-1982, 1997.

P. Mulder, H. Boujedaini, and V. Richard, Selective endothelin-A versus combined endothelin-A/endothelin-B receptor blockade in rat chronic heart failure, Circulation, vol.102, pp.491-493, 2000.

P. Mulder, S. Barbier, and A. Chagraoui, Long-term heart rate reduction induced by the selective I (f) current inhibitor ivabradine improves left ventricular function and intrinsic myocardial structure in congestive heart failure, Circulation, vol.109, pp.1674-1679, 2004.

P. Milliez, S. Messaoudi, and J. Nehme, Beneficial effects of delayed ivabradine treatment on cardiac anatomical and electrical remodeling in rat severe chronic heart failure, Am J Physiol Heart Circ Physiol, vol.296, pp.435-441, 2009.

L. P. Christensen, R. L. Zhang, and W. Zheng, Postmyocardial infarction remodeling and coronary reserve: effects of ivabradine and beta blockade therapy, Am J Physiol Heart Circ Physiol, vol.297, pp.322-330, 2009.

D. J. Sahn, A. Demaria, and J. Kisslo, Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements, Circulation, vol.58, pp.1072-1083, 1978.

V. Mellin, M. Isabelle, and A. Oudot, Transient reduction in myocardial free oxygen radical levels is involved in the improved cardiac function and structure after long-term allopurinol treatment initiated in established chronic heart failure, Eur Heart J, vol.26, pp.1544-1550, 2005.

Y. Fang, L. Nicol, and N. Harouki, Improvement of left ventricular diastolic function induced by beta-blockade a comparison between nebivolol and metoprolol, J Mol Cell Cardiol, vol.51, pp.168-176, 2011.

P. Mulder, V. Mellin, and J. Favre, Aldosterone synthase inhibition improves cardiovascular function and structure in rats with heart failure: a comparison with spironolactone, Eur Heart J, vol.29, pp.2171-2179, 2008.

R. Cao, E. Brakenhielm, and R. Pawliuk, Angiogenic synergism, vascular stability and improvement of hind-limb ischemia by a combination of PDGF-BB and FGF-2, Nat Med, vol.9, pp.604-613, 2003.

K. Laude, J. Favre, and C. Thuillez, NO produced by endothelial NO synthase is a mediator of delayed preconditioning-induced endothelial protection, Am J Physiol Heart Circ Physiol, vol.284, pp.2053-2060, 2003.

M. Vercauteren, R. E. Devaux, and C. , Improvement of peripheral endothelial dysfunction by protein tyrosine phosphatase inhibitors in heart failure, Circulation, vol.114, pp.2498-2507, 2006.

S. E. Litwin, S. E. Katz, and J. P. Morgan, Serial echocardiographic assessment of left ventricular geometry and function after large myocardial infarction in the rat, Circulation, vol.89, pp.345-354, 1994.

P. Mulder, B. Devaux, and V. Richard, Early versus delayed angiotensinconverting enzyme inhibition in experimental chronic heart failure. Effects on survival, hemodynamics, and cardiovascular remodeling, Circulation, vol.95, pp.1314-1319, 1997.

R. Varin, P. Mulder, and F. Tamion, Improvement of endothelial function by chronic angiotensin-converting enzyme inhibition in heart failure: role of nitric oxide, prostanoids, oxidant stress, and bradykinin, Circulation, vol.102, pp.351-356, 2000.

N. Ulu, R. H. Henning, and M. Goris, Effects of ivabradine and metoprolol on cardiac angiogenesis and endothelial dysfunction in rats with heart failure, J Cardiovasc Pharmacol, vol.53, pp.9-17, 2009.

M. Maczewski and U. Mackiewicz, Effect of metoprolol and ivabradine on left ventricular remodelling and Ca 2+ handling in the post-infarction rat heart, Cardiovasc Res, vol.79, pp.42-51, 2008.

J. C. Tardif, E. O'meara, and M. Komajda, Effects of selective heart rate reduction with ivabradine on left ventricular remodelling and function: results from the SHIFT echocardiography substudy, Eur Heart J, vol.32, pp.2507-2515, 2011.

C. M. Matter, L. Mandinov, and P. A. Kaufmann, Effect of NO donors on LV diastolic function in patients with severe pressure-overload hypertrophy, Circulation, vol.99, pp.2396-2401, 1999.

H. Boudoulas, S. E. Rittgers, and R. P. Lewis, Changes in diastolic time with various pharmacologic agents: implication for myocardial perfusion, Circulation, vol.60, pp.164-169, 1979.

B. D. Guth, G. Heusch, and R. Seitelberger, Elimination of exerciseinduced regional myocardial dysfunction by a bradycardiac agent in dogs with chronic coronary stenosis, Circulation, vol.75, pp.661-669, 1987.

B. D. Guth, G. Heusch, and R. Seitelberger, Role of heart rate reduction in the treatment of exercise-induced myocardial ischaemia, Eur Heart J, vol.8, pp.61-68, 1987.

B. D. Guth, G. Heusch, and R. Seitelberger, Mechanism of beneficial effect of beta-adrenergic blockade on exercise-induced myocardial ischemia in conscious dogs, Circ Res, vol.60, pp.738-746, 1987.

C. Devaux, M. Iglarz, and V. Richard, Chronic decrease in flow contributes to heart failure-induced endothelial dysfunction in rats, Clin Exp Pharmacol Physiol, vol.31, pp.302-305, 2004.

V. M. Miller, L. L. Aarhus, and P. M. Vanhoutte, Modulation of endotheliumdependent responses by chronic alterations of blood flow, Am J Physiol, vol.251, pp.520-527, 1986.

F. Custodis, M. Baumhakel, and N. Schlimmer, Heart rate reduction by ivabradine reduces oxidative stress, improves endothelial function, and prevents atherosclerosis in apolipoprotein E-deficient mice, Circulation, vol.117, pp.2377-2387, 2008.

N. Couvreur, R. Tissier, and S. Pons, Chronic heart rate reduction with ivabradine improves systolic function of the reperfused heart through a dual mechanism involving a direct mechanical effect and a long-term increase in FKBP12/12.6 expression, Eur Heart J, vol.31, pp.5129-5137, 2009.
URL : https://hal.archives-ouvertes.fr/inserm-00500900

E. I. Dedkov, W. Zheng, and L. P. Christensen, Preservation of coronary reserve by ivabradine-induced reduction in heart rate in infarcted rats is associated with decrease in perivascular collagen, Am J Physiol Heart Circ Physiol, vol.293, pp.590-598, 2007.

L. Lei, R. Zhou, and W. Zheng, Bradycardia induces angiogenesis, increases coronary reserve, and preserves function of the postinfarcted heart, Circulation, vol.110, pp.796-802, 2004.

C. Waller, T. Engelhorn, and K. H. Hiller, Impaired resting perfusion in viable myocardium distal to chronic coronary stenosis in rats, Am J Physiol Heart Circ Physiol, vol.288, pp.2588-2593, 2005.

K. H. Hiller, P. Ruile, and G. Kraus, Tissue ACE inhibition improves microcirculation in remote myocardium after coronary stenosis: MR imaging study in rats, Microvasc Res, vol.110, pp.796-802, 2004.